Delivery Order SPE2DB20D1047-SPE2DB25FF72M
- Not listed
- The Defense Logistics Agency awarded a $4,771.95 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,331.02 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure. This delivery order is executable through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,893.98 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 packs) on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,049.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $10,096 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside contract represents a standard pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,419.07 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on August 1, 2025. This firm fixed-price delivery order, which is part of a non-set-aside competitive procurement, is scheduled for completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,436.87 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565405204 - NURTEC ODT 75 MG TABLET 8S. This delivery order is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF72MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain, supporting military and veteran healthcare systems with a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides global pharmaceutical support capabilities enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/16/25 |